Form 4 for SPRY ARS Pharmaceuticals, Inc.
Accepted 2024-12-04 00:00:00 ET · period of report 2024-12-02 · accession 0001415889-24-028351 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-04 | 2024-12-02+ | SPRY | Chakma Justin | Chief Business Off | S - Sale+OE | $13.43 | -90.0K | 136.4K | -40% | -$1.21M |
| DM | 2024-12-04 | 2024-12-02+ | SPRY | Chakma Justin | Chief Business Off | M - OptEx | $0.84 | +90.0K | 181.4K | +98% | +$75.6K |
| DM | 2024-12-04 | 2024-12-02+ | SPRY | Chakma Justin | Chief Business Off | M - OptEx | $0.00 | -90.0K | 194.6K | -32% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-03 | S | D | 45,000 | $13.19 | 136,380 | D | — | — | (F2) The weighted average sale price for the transaction reported was $13.1867, and the range of prices were between $13.00 and $13.38. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. |
| 2 | Common | Common Stock | 2024-12-03 | M | A | 3,260 | $0.84 | 139,640 | D | — | — | |
| 3 | Common | Common Stock | 2024-12-03 | M | A | 41,740 | $0.84 | 181,380 | D | — | — | |
| 4 | Common | Common Stock | 2024-12-02 | M | A | 45,000 | $0.84 | 181,380 | D | — | — | |
| 5 | Common | Common Stock | 2024-12-02 | S | D | 45,000 | $13.67 | 136,380 | D | — | — | (F1) The weighted average sale price for the transaction reported was $13.6715, and the range of prices were between $13.324 and $14.035. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-12-03 | M | D | 3,260 | $0.00 | 0 | D | $0.84 · — to 2029-12-16 | 3,260 Common Stock | (F3) Immediately exercisable. |
| 7 | Derivative | Stock Option (Right to Buy) | 2024-12-02 | M | D | 45,000 | $0.00 | 3,260 | D | $0.84 · — to 2029-12-16 | 45,000 Common Stock | (F3) Immediately exercisable. |
| 8 | Derivative | Stock Option (Right to Buy) | 2024-12-03 | M | D | 41,740 | $0.00 | 194,640 | D | $0.84 · — to 2029-07-04 | 41,740 Common Stock | (F3) Immediately exercisable. |